OA11994A - Précurseurs de seis de bis-ammonium quatemaire et leurs applications comme pro-drogues ayant une activité anti-parasitaire. - Google Patents

Précurseurs de seis de bis-ammonium quatemaire et leurs applications comme pro-drogues ayant une activité anti-parasitaire. Download PDF

Info

Publication number
OA11994A
OA11994A OA1200200020A OA1200200020A OA11994A OA 11994 A OA11994 A OA 11994A OA 1200200020 A OA1200200020 A OA 1200200020A OA 1200200020 A OA1200200020 A OA 1200200020A OA 11994 A OA11994 A OA 11994A
Authority
OA
OAPI
Prior art keywords
group
alkyl
formula
radical
represent
Prior art date
Application number
OA1200200020A
Other languages
English (en)
French (fr)
Inventor
Henri Vial
Michele Calas
Marie-Laure Ancelin
Jean-Jacques Bourguignon
Valerie Vidal
Eric Rubi
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Publication of OA11994A publication Critical patent/OA11994A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/541—Organic ions forming an ion pair complex with the pharmacologically or therapeutically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C211/09—Diamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40—Y being a hydrogen or a carbon atom
    • C07C323/41—Y being a hydrogen or an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/20—Esters of monothiocarboxylic acids
    • C07C327/30—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/20—Esters of monothiocarboxylic acids
    • C07C327/32—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C07C327/34—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups with amino groups bound to the same hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
OA1200200020A 1999-07-21 2000-07-21 Précurseurs de seis de bis-ammonium quatemaire et leurs applications comme pro-drogues ayant une activité anti-parasitaire. OA11994A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9909471A FR2796642B1 (fr) 1999-07-21 1999-07-21 Precurseurs de sels de bis-ammonium quaternaire et leurs applications comme prodrogues ayant une activite anti-parasitaire

Publications (1)

Publication Number Publication Date
OA11994A true OA11994A (fr) 2006-04-18

Family

ID=9548361

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200200020A OA11994A (fr) 1999-07-21 2000-07-21 Précurseurs de seis de bis-ammonium quatemaire et leurs applications comme pro-drogues ayant une activité anti-parasitaire.

Country Status (21)

Country Link
US (1) US6972343B1 (zh)
EP (1) EP1196371B1 (zh)
JP (1) JP4431853B2 (zh)
CN (2) CN100467440C (zh)
AP (1) AP1412A (zh)
AT (1) ATE308507T1 (zh)
AU (1) AU783267C (zh)
BR (1) BR0012601A (zh)
CA (1) CA2379891C (zh)
DE (1) DE60023703T2 (zh)
DK (1) DK1196371T3 (zh)
ES (1) ES2252050T3 (zh)
FR (1) FR2796642B1 (zh)
HK (1) HK1047922B (zh)
HU (1) HU229084B1 (zh)
IL (2) IL147710A0 (zh)
MX (1) MXPA02000711A (zh)
OA (1) OA11994A (zh)
PL (1) PL200314B1 (zh)
WO (1) WO2001005742A1 (zh)
ZA (1) ZA200200903B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2547972A1 (en) * 2003-11-24 2005-06-09 Georgia State University Research Foundation, Inc. Fused ring dicationic anti-protozoan agents and their prodrugs
FR2926993B1 (fr) 2008-02-06 2011-03-11 Sanofi Aventis Association entre un sel de bis-thiazolium ou l'un de ses precurseurs et l'artemisinine ou l'un de ses derives pour le traitement du paludisme
CN101711527B (zh) * 2009-12-31 2013-02-20 蚌埠丰原医药科技发展有限公司 一种杀菌组合物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3131220A (en) * 1958-07-09 1964-04-28 Smith Kline French Lab Tetrasubstituted polymethylenediamine salts
GB1006790A (en) * 1963-04-28 1965-10-06 Takeda Chemical Industries Ltd New thiamine derivatives and the preparation thereof
FR2751967B1 (fr) * 1996-07-31 1998-10-09 Virbac Sa Agents antipaludeens et antibabesioses et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
FR2796642B1 (fr) 2001-10-19
US6972343B1 (en) 2005-12-06
CN1733699A (zh) 2006-02-15
HU229084B1 (en) 2013-07-29
EP1196371A1 (fr) 2002-04-17
ZA200200903B (en) 2003-07-30
HUP0202108A2 (en) 2002-10-28
CA2379891C (fr) 2014-03-25
IL147710A (en) 2007-08-19
AU783267C (en) 2006-08-17
DK1196371T3 (da) 2006-03-20
CN1372539A (zh) 2002-10-02
PL353592A1 (en) 2003-12-01
CA2379891A1 (fr) 2001-01-25
JP2003505357A (ja) 2003-02-12
HK1047922A1 (en) 2003-03-14
MXPA02000711A (es) 2003-07-14
IL147710A0 (en) 2002-08-14
ES2252050T3 (es) 2006-05-16
CN1181043C (zh) 2004-12-22
PL200314B1 (pl) 2008-12-31
HK1047922B (zh) 2006-10-13
CN100467440C (zh) 2009-03-11
DE60023703D1 (de) 2005-12-08
AP2002002412A0 (en) 2002-03-31
AP1412A (en) 2005-05-17
AU7006900A (en) 2001-02-05
BR0012601A (pt) 2002-05-21
ATE308507T1 (de) 2005-11-15
HUP0202108A3 (en) 2005-06-28
DE60023703T2 (de) 2006-07-27
FR2796642A1 (fr) 2001-01-26
JP4431853B2 (ja) 2010-03-17
WO2001005742A1 (fr) 2001-01-25
AU783267B2 (en) 2005-10-06
EP1196371B1 (fr) 2005-11-02

Similar Documents

Publication Publication Date Title
FR2823209A1 (fr) Nouvelles thiohydantoines et leur utilisation en therapeutique
FR2562892A1 (fr) Nouveaux dihydropyridinyldicarboxylates amides et esters, utilisation de ces composes comme medicament, compositions pharmaceutiques comprenant de tels composes et procede pour la preparation de tels composes
RU2361855C2 (ru) Аминобензофеноны
KR840001019B1 (ko) 치환된 푸란의 제조방법
FR2672213A1 (fr) Utilisation de derives 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridiniques comme capteurs de radicaux libres.
FR2480284A1 (fr) Amines antihypertensives, leur procede de preparation et compositions antihypertensives en contenant.
OA11994A (fr) Précurseurs de seis de bis-ammonium quatemaire et leurs applications comme pro-drogues ayant une activité anti-parasitaire.
EP0364350B1 (fr) Dérivés de méthyl-4[(phényl-4 pipérazinyl-1)-2 éthyl]-5 thiazole, leur procédé de préparation et les compositions pharmaceutiques en contenant
CH661514A5 (fr) Derives du thiadiazole-1,3,4, procede pour leur preparation et agents antiulcereux les contenant.
WO1996011910A1 (fr) Bis-2-aminopyridines, leur procede de preparation et leurs applications contre les parasitoses
LU81554A1 (de) Alkylthiophenoxyalkylamines
CA2491989C (fr) Composes a activite anti-parasitaire et medicaments les renfermant
OA13294A (fr) Molécules duales contenant un dérivé peroxydique, leur synthèse et leurs applications thérapeutiques.
WO2003099269A1 (en) Cinnamic acid dimers, their preparation and the use thereof for treating neurodegenerative disease
FR2507180A1 (fr) Nouvelles phenylalkylamines, leur preparation et leur application comme medicaments
US7038061B2 (en) Crystalline anhydrous and monohydrate benzoate salts of (2′S,3S)-3-hydroxy-N-(2-[N-methyl-N-4-(N-propylamino-carbonyl)phenyl]amino-2-phenyl)-ethylpyrrolidine
FR2539414A1 (fr) Derives de la pyrimidine, leur procede de preparation et les medicaments ayant une activite sur le systeme nerveux central qui en contiennent
JPH02218651A (ja) ブチニルアミン誘導体
JPH05345768A (ja) 新規トリアゾール化合物及び該化合物を有効成分とする抗真菌剤
US20040063696A1 (en) 1,1-dioxo-2h-1,2-benzothiazine-3-carboxamide derivatives,method for preparing same and pharmaceutical compositions comprising same